Sentiens, the technology company that has developed and patented BotanicBoost in the Novus Twig and eTwig, announced the results of its first clinical study on the satisfaction and performance of BotanicBoost for smokers. More details on the study can be found in this article from Sentiens .
The research study was a randomized, double-blind, placebo-controlled design comparing the Sentiens BotanicBoost® product with placebo versions (without BotanicBoost®). One of the delivery products was a heated device intended to deliver an aerosol of BotanicBoost, very similar to the eTwig by Novus. The other product is paper based and delivers BotanicBoost in an invisible vapor form, very similar to the Novus Twig.
The study entitled “Evaluation of a Botanical Extract that Mimics the Respiratory Cues of Cigarette Smoke”, was published in the Journal of Smoking Cessation and can be accessed at www.cambridge.org/core/journals/journal-of-smoking-cessation. According to Rose Research, the satisfaction level of BotanicBoost® based products was greater than placebo at a statistically significant level. Further, the actual ratings compared equally or better than other products RRC has tested, including various e-cigarettes and other nicotine containing products for the industry. The researchers were surprised and impressed with the strong results especially in comparison to nicotine based products. Regarding the safety of BotanicBoost, they found no indications of any pulmonary or cardiovascular issues, or other adverse events. These results validate our own tests on both satisfaction and safety.